 Laura Greene
Concepts (60)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mevalonate Kinase Deficiency | 1 | 2023 | 1 | 0.810 |
Why?
| | Vasculitis, Leukocytoclastic, Cutaneous | 1 | 2023 | 8 | 0.800 |
Why?
| | Sweet Syndrome | 1 | 2023 | 10 | 0.800 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2023 | 364 | 0.570 |
Why?
| | Dermatomycoses | 1 | 2015 | 8 | 0.470 |
Why?
| | Voriconazole | 1 | 2015 | 21 | 0.460 |
Why?
| | Ascomycota | 1 | 2015 | 26 | 0.460 |
Why?
| | Sebaceous Gland Diseases | 1 | 2014 | 1 | 0.440 |
Why?
| | Lymphadenitis | 1 | 2014 | 6 | 0.440 |
Why?
| | Neutropenia | 1 | 2015 | 154 | 0.430 |
Why?
| | Immunocompromised Host | 1 | 2015 | 202 | 0.410 |
Why?
| | Exanthema | 2 | 2024 | 86 | 0.380 |
Why?
| | Neutrophils | 1 | 2014 | 1123 | 0.280 |
Why?
| | Dengue Vaccines | 1 | 2024 | 11 | 0.220 |
Why?
| | Dengue Virus | 1 | 2024 | 60 | 0.210 |
Why?
| | Epithelioid Cells | 1 | 2003 | 9 | 0.200 |
Why?
| | Dengue | 1 | 2024 | 91 | 0.200 |
Why?
| | Genome, Viral | 1 | 2024 | 214 | 0.190 |
Why?
| | Candidiasis, Cutaneous | 1 | 2022 | 2 | 0.190 |
Why?
| | Uterine Neoplasms | 1 | 2003 | 98 | 0.180 |
Why?
| | Skin Neoplasms | 2 | 2019 | 848 | 0.170 |
Why?
| | Infant, Newborn, Diseases | 1 | 2022 | 115 | 0.160 |
Why?
| | Foot Dermatoses | 1 | 2020 | 4 | 0.160 |
Why?
| | Keratosis | 1 | 2020 | 16 | 0.160 |
Why?
| | Dermatologic Surgical Procedures | 1 | 2019 | 23 | 0.150 |
Why?
| | Lichenoid Eruptions | 1 | 2018 | 2 | 0.140 |
Why?
| | Drug Eruptions | 1 | 2018 | 28 | 0.140 |
Why?
| | Nevus | 1 | 2018 | 26 | 0.140 |
Why?
| | Patient Care Planning | 1 | 2019 | 170 | 0.140 |
Why?
| | Ipilimumab | 1 | 2018 | 40 | 0.140 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2019 | 299 | 0.120 |
Why?
| | Antineoplastic Agents, Immunological | 1 | 2018 | 198 | 0.120 |
Why?
| | Balanitis | 1 | 2014 | 1 | 0.110 |
Why?
| | Penis | 1 | 2014 | 33 | 0.110 |
Why?
| | Infant, Newborn | 2 | 2023 | 6435 | 0.110 |
Why?
| | Torso | 1 | 2014 | 36 | 0.110 |
Why?
| | Plasma Cells | 1 | 2014 | 79 | 0.100 |
Why?
| | Patient Care Team | 1 | 2019 | 696 | 0.100 |
Why?
| | Face | 1 | 2014 | 174 | 0.100 |
Why?
| | Melanoma | 1 | 2018 | 759 | 0.090 |
Why?
| | Humans | 10 | 2024 | 145140 | 0.070 |
Why?
| | Skin | 2 | 2024 | 753 | 0.070 |
Why?
| | Vaccines, Attenuated | 1 | 2024 | 129 | 0.050 |
Why?
| | MART-1 Antigen | 1 | 2003 | 8 | 0.050 |
Why?
| | Young Adult | 2 | 2024 | 14176 | 0.050 |
Why?
| | Male | 6 | 2024 | 72664 | 0.040 |
Why?
| | Antigens, Neoplasm | 1 | 2003 | 271 | 0.040 |
Why?
| | Antifungal Agents | 1 | 2022 | 150 | 0.040 |
Why?
| | Biopsy | 1 | 2024 | 1079 | 0.040 |
Why?
| | Adult | 3 | 2024 | 40665 | 0.040 |
Why?
| | Neoplasm Proteins | 1 | 2003 | 441 | 0.040 |
Why?
| | Immunohistochemistry | 1 | 2003 | 1713 | 0.040 |
Why?
| | Female | 4 | 2024 | 78636 | 0.040 |
Why?
| | Middle Aged | 4 | 2024 | 36126 | 0.030 |
Why?
| | Disease Management | 1 | 2019 | 651 | 0.030 |
Why?
| | Circumcision, Male | 1 | 2014 | 16 | 0.030 |
Why?
| | Inflammation | 1 | 2024 | 2876 | 0.020 |
Why?
| | Aged | 2 | 2019 | 26096 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2019 | 8318 | 0.020 |
Why?
| | Adolescent | 1 | 2024 | 22479 | 0.010 |
Why?
|
|
Greene's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|